Catalyst Capital Advisors LLC lessened its stake in Amphenol Co. (NYSE:APH – Free Report) by 3.2% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 66,065 shares of the electronics maker’s stock after selling 2,185 shares during the quarter. Catalyst Capital Advisors LLC’s holdings in Amphenol were worth $4,305,000 at the end of the most recent reporting period.
Other large investors have also recently added to or reduced their stakes in the company. Beacon Capital Management LLC increased its stake in Amphenol by 121.2% in the 2nd quarter. Beacon Capital Management LLC now owns 376 shares of the electronics maker’s stock valued at $25,000 after buying an additional 206 shares during the period. New England Capital Financial Advisors LLC increased its stake in Amphenol by 100.0% in the 2nd quarter. New England Capital Financial Advisors LLC now owns 376 shares of the electronics maker’s stock valued at $25,000 after buying an additional 188 shares during the period. Opal Wealth Advisors LLC acquired a new position in Amphenol in the 2nd quarter valued at approximately $29,000. Trifecta Capital Advisors LLC increased its stake in Amphenol by 352.1% in the 3rd quarter. Trifecta Capital Advisors LLC now owns 434 shares of the electronics maker’s stock valued at $28,000 after buying an additional 338 shares during the period. Finally, Sachetta LLC increased its stake in Amphenol by 131.1% in the 2nd quarter. Sachetta LLC now owns 439 shares of the electronics maker’s stock valued at $27,000 after buying an additional 249 shares during the period. Institutional investors and hedge funds own 97.01% of the company’s stock.
Amphenol Stock Up 0.5 %
Shares of NYSE APH opened at $68.22 on Tuesday. The firm has a market capitalization of $82.25 billion, a PE ratio of 39.21, a price-to-earnings-growth ratio of 2.23 and a beta of 1.23. The company has a current ratio of 1.99, a quick ratio of 1.33 and a debt-to-equity ratio of 0.53. Amphenol Co. has a 1 year low of $41.96 and a 1 year high of $71.20. The firm’s 50-day moving average is $65.26 and its 200-day moving average is $65.18.
Amphenol Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 8th. Investors of record on Tuesday, December 17th will be paid a dividend of $0.165 per share. This represents a $0.66 annualized dividend and a yield of 0.97%. The ex-dividend date of this dividend is Tuesday, December 17th. Amphenol’s payout ratio is 37.93%.
Insider Buying and Selling
In related news, VP Lance E. D’amico sold 100,000 shares of Amphenol stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $65.63, for a total transaction of $6,563,000.00. Following the transaction, the vice president now owns 51,400 shares of the company’s stock, valued at $3,373,382. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other Amphenol news, CEO Richard Adam Norwitt sold 900,672 shares of Amphenol stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $68.81, for a total value of $61,975,240.32. Following the transaction, the chief executive officer now owns 1,934,848 shares of the company’s stock, valued at approximately $133,136,890.88. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, VP Lance E. D’amico sold 100,000 shares of Amphenol stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $65.63, for a total transaction of $6,563,000.00. Following the completion of the sale, the vice president now owns 51,400 shares in the company, valued at $3,373,382. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 1,630,672 shares of company stock valued at $110,992,440 in the last 90 days. 1.80% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
Several research analysts have weighed in on the stock. Truist Financial upped their price objective on shares of Amphenol from $76.00 to $82.00 and gave the company a “buy” rating in a research note on Thursday, October 24th. UBS Group increased their price target on shares of Amphenol from $69.00 to $80.00 and gave the stock a “buy” rating in a research note on Wednesday, July 10th. Robert W. Baird upped their price objective on shares of Amphenol from $71.00 to $77.00 and gave the stock an “outperform” rating in a report on Thursday, October 24th. Bank of America upped their price objective on shares of Amphenol from $70.00 to $74.00 and gave the stock a “neutral” rating in a report on Thursday, October 24th. Finally, TD Cowen increased their price objective on shares of Amphenol from $60.00 to $63.00 and gave the company a “hold” rating in a research note on Friday, October 25th. Five analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $69.63.
Get Our Latest Stock Analysis on APH
About Amphenol
Amphenol Corporation, together with its subsidiaries, primarily designs, manufactures, and markets electrical, electronic, and fiber optic connectors in the United States, China, and internationally. It operates through three segments: Harsh Environment Solutions, Communications Solutions, and Interconnect and Sensor Systems.
Read More
- Five stocks we like better than Amphenol
- What is an Earnings Surprise?
- Intel: Is Now the Time to Be Brave?Â
- How to Calculate Inflation Rate
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Want to see what other hedge funds are holding APH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amphenol Co. (NYSE:APH – Free Report).
Receive News & Ratings for Amphenol Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amphenol and related companies with MarketBeat.com's FREE daily email newsletter.